Evidence map›Paper›PMID 23978373›Full record

ReviewCurrent opinion in chemical biology2013

trans-Cyclooctene--a stable, voracious dienophile for bioorthogonal labeling.

Ramajeyam Selvaraj, Joseph M Fox

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 218 citations in OpenAlex.

  1. Review
  2. Article
  3. ACS infectious diseases · 2026
    Article
  4. Review
  5. Azo-Povarov Cycloaddition ofThe Journal of organic chemistry · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. ACS omega · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Minimalist TetrazineJournal of the American Chemical Society · 2024
    Article
  18. Review
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ramajeyam SelvarajBrown Laboratories, Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716, United States.
Joseph M Fox
University of Delaware · US

Funding

UDE COBRE: STRAINED MOLECULES FOR SYNTHESIS OF UNNATURAL AMINO ACIDSP20RR017716 · NCRR · UNIVERSITY OF DELAWARE · PI POCHAN, DARRIN J · 2002 to 2011
$16.9M
SELECTIVE METHODS FOR SYNTHESIS WITH STRAINED MOLECULES AND CARBENOIDSR01GM068640 · NIGMS · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2004 to 2012
$2.7M
Molecular Design of Advanced BiomaterialsP20GM103541 · NIGMS · UNIVERSITY OF DELAWARE · PI POLENOVA, TATYANA · 2012 to 2012
$2.1M
NCRR NIH HHS P20 RR017716NCRR NIH HHS P20RR017716NIGMS NIH HHS P20 GM103541NIGMS NIH HHS R01 GM068640
6 · The paper itself

Abstract

Discussed herein is the development and advancement of trans-cyclooctene as a tool for facilitating bioorthogonal labeling through reactions with s-tetrazines. While a number of strained alkenes have been shown to combine with tetrazines for applications in bioorthogonal labeling, trans-cyclooctene enables fastest reactivity at low concentration with rate constants in excess of k2=10(6) M(-1) s(-1). In the present article, we describe advances in computation and synthesis that have enabled applications in chemical biology and nuclear medicine.

Indexed as

AnimalsCell SurvivalCyclooctanesHydrophobic and Hydrophilic InteractionsNuclear MedicineProteinscyclooctaneCyclooctanesProteins

Identifiers

PMID23978373
PMCPMC3925366
OpenAlexW1963598974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.